"That's clearly a myth," says George Saade, chief of maternal-fetal medicine at The University of Texas Medical Branch in Galveston.

“这完全是误传，”加尔维斯敦德州大学医疗分部母胎医学行政长官George Saade说。

youdao

"We know safety-wise, there's zero question, " said Dr. Gary Hankins of the University of Texas Medical Branch in Galveston, who headed one of the company-financed studies of Diclegis that led to its approval.

NPR: FDA Approves Return Of Drug For Morning Sickness